diVa™ Laser by Sciton
AVAILABLE AT VEGA BACK BAY
AVAILABLE AT VEGA BACK BAY
diVa® by Sciton is a customizable fractional laser treatment designed specifically for vaginal tissue.
Using Sciton’s dual-wavelength laser technology, diVa delivers controlled fractional energy to vaginal tissue during a brief in-office procedure. Treatment parameters can be individualized according to a patient’s anatomy, medical history, and treatment goals.
Changes in vaginal tissue can occur with childbirth, aging, hormonal changes, and menopause. Patients considering diVa should first undergo an appropriate clinical evaluation to determine the cause of their symptoms and whether laser treatment is an appropriate option.
diVa uses two complementary laser wavelengths delivered through a specialized vaginal handpiece.
The treatment creates controlled microscopic zones within the vaginal tissue while leaving surrounding tissue intact to support healing.
The system allows the provider to customize treatment depth and energy according to the tissue being treated and the individual patient.
Rather than describing this as simply “tightening” the vagina, I think this gives patients a much better understanding of what the device actually does.
Women may seek evaluation because of changes in vaginal health following:
Symptoms such as dryness, discomfort, painful intercourse, urinary symptoms, or changes in sexual function can have many causes. These symptoms should be clinically evaluated rather than assuming that laser treatment is the appropriate solution.
Depending on the underlying problem, treatments other than diVa—including vaginal moisturizers, pelvic-floor therapy, prescription medications, or local hormonal therapy—may be more appropriate.
The Sciton JOULE laser platform used to deliver diVa treatment has FDA clearance for coagulation and ablation of soft tissue, including gynecologic and mucosal tissue.
This clearance should not be interpreted to mean that the FDA has specifically approved diVa as a treatment for every symptom sometimes associated with menopause, childbirth, sexual dysfunction, or urinary incontinence.
Your Vega Vitality provider will discuss the intended treatment, available evidence, alternatives, and potential risks as they apply to your individual situation.
Before treatment, your provider will review your medical history and perform an appropriate examination to determine whether diVa is suitable for you.
During the procedure, the specialized diVa handpiece is positioned within the vaginal canal and delivers fractional laser energy according to predetermined treatment settings.
Treatment itself is relatively brief. The appropriate treatment protocol and number of sessions depend on the individual patient and treatment plan.
Individual responses to diVa® treatment vary depending on treatment settings, the condition of the vaginal tissue, and individual healing. Temporary redness, swelling, warmth, spotting, discharge, or sensitivity may occur following treatment. More intensive treatments may result in a longer recovery period.
Please contact Vega Vitality promptly if you experience severe or increasing pain, heavy bleeding, fever, foul-smelling or unusual discharge, worsening swelling or redness, difficulty urinating, sores or blistering, or any symptoms that concern you.
Temporary effects may include redness, swelling, spotting, discharge, sensitivity, or discomfort following treatment.
Patients may be instructed to temporarily avoid intercourse, tampons, strenuous exercise, hot tubs, swimming, or other activities during the initial healing period.
Your provider will give you specific post-treatment instructions based on the treatment performed.
Treatment plans should be individualized.
Some diVa protocols have historically used a series of treatments followed by reassessment or maintenance, but the appropriate number and interval should depend on the patient’s clinical findings, response, and treatment goals.
Your Vega Vitality provider will recommend a plan after consultation rather than automatically prescribing the same treatment series for every patient.
Menopause can produce significant changes in vulvovaginal and urinary health as estrogen levels decline. Collectively, many of these symptoms are described clinically as genitourinary syndrome of menopause (GSM).
Symptoms can include dryness, irritation, painful intercourse, and urinary complaints.
However, these symptoms have multiple evidence-based treatment options, and laser treatment should not automatically be considered first-line therapy. A clinical evaluation can help determine whether moisturizers, lubricants, vaginal estrogen or other prescription therapy, pelvic-floor treatment, laser treatment, or another approach is most appropriate.
Pregnancy and childbirth can produce several different changes, including pelvic-floor dysfunction, prolapse, scar-related symptoms, and changes in vaginal tissue. diVa may be considered in selected patients, but it is not a substitute for evaluation of postpartum pelvic-floor or gynecologic problems.
No. Elective vaginal laser treatment should not be performed during pregnancy.
No. They are fundamentally different treatments. For patients with menopausal genitourinary symptoms, local hormonal and nonhormonal therapies may be appropriate depending on medical history and symptoms.
Sexual function is influenced by many physical, hormonal, psychological, and relationship factors. Patients experiencing pain or changes in sexual function should receive an appropriate clinical evaluation. diVa may be a part of the treatment plan.
Vaginal and genitourinary symptoms deserve the same individualized medical approach as any other health concern.
At Vega Vitality, consultation begins with understanding your symptoms, medical history, and goals. When appropriate, diVa may be considered as one component of an individualized treatment plan.